1. Home/
  2. Compounds/
  3. selumetinib:PLX-4032 (8:1 mol/mol)

selumetinib:PLX-4032 (8:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2selumetinib:PLX-4032 (8:1 mol/mol)
PharmacoGx selumetinib:PLX-4032 (8:1 mol/mol)

FDA Approval Status

Not Approved
Dataset Select
Download Data as CSV

Top molecular features associated with response to selumetinib:PLX-4032 (8:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA TOR4A CTRPv2 pan-cancer AAC 0.19 4e-07
mRNA SGTB CTRPv2 pan-cancer AAC -0.19 4e-07
mRNA SLC30A1 CTRPv2 pan-cancer AAC 0.18 4e-07
mRNA CDCA8 CTRPv2 pan-cancer AAC -0.18 4e-07
mRNA RNF149 CTRPv2 pan-cancer AAC 0.21 4e-07
mRNA USP28 CTRPv2 pan-cancer AAC -0.18 4e-07
mRNA MST1R CTRPv2 pan-cancer AAC 0.22 4e-07
mRNA PIAS2 CTRPv2 pan-cancer AAC -0.19 4e-07
mRNA MFSD12 CTRPv2 pan-cancer AAC 0.23 4e-07
mRNA MYL10 CTRPv2 pan-cancer AAC 0.18 4e-07
Download CSV